Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2081933 | Drug Discovery Today: Disease Mechanisms | 2007 | 10 Pages |
Abstract
Cystic fibrosis patients exhibit lung disease consistent with a failure of innate airway defense mechanisms. The link between abnormal ion transport and disease initiation and progression is not fully understood, but airway mucus dehydration seems paramount in the initiation of CF lung disease. New therapies are currently in development that target the ion transport defects in CF with the intention of rehydrating airway surfaces.
Section editor:Clay Braden Marsh – Department of Internal Medicine, Ohio State University, USA
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Mark T. Clunes, Richard C. Boucher,